BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31070153)

  • 1. Serum procalcitonin levels in chronic obstructive pulmonary disease patients in North Indian Population.
    Pandey S; Garg R; Kant S; Verma A; Gaur P
    Ann Afr Med; 2019; 18(2):103-107. PubMed ID: 31070153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.
    Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL
    J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
    Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
    Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Song W; Wang Y; Tian F; Ge L; Shang X; Zeng Q; Feng N; Fan J; Wang J; Ma X
    Dis Markers; 2021; 2021():8879401. PubMed ID: 33791046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.
    Ye YP; Zhao H; Kang T; Zhao LH; Li N; Chen J; Peng XX
    Chron Respir Dis; 2022; 19():14799731221108516. PubMed ID: 35830291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease].
    Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):444-7. PubMed ID: 17045042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy.
    Bremmer DN; Moffa MA; Ma K; Bean HR; Snatchko J; Trienski TL; Watson C; Walsh TL
    Clin Infect Dis; 2019 Feb; 68(5):725-730. PubMed ID: 29982350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
    Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
    Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Qian W; Huang GZ
    Immunol Invest; 2016 Aug; 45(6):490-503. PubMed ID: 27224474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: A prospective observational study.
    Titova E; Christensen A; Henriksen AH; Steinshamn S; Åsberg A
    Chron Respir Dis; 2019; 16():1479972318769762. PubMed ID: 29848051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin: Is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation?
    Pazarli AC; Koseoglu HI; Doruk S; Sahin S; Etikan I; Celikel S; Berktas B
    J Res Med Sci; 2012 Nov; 17(11):1047-51. PubMed ID: 23833579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance.
    Wang J; Cao B
    Curr Opin Pulm Med; 2019 Mar; 25(2):158-164. PubMed ID: 30550505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
    Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
    COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin (PCT) Improves the Accuracy and Sensitivity of Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation (DECAF) Score in Predicting AECOPD Patients Admission to ICU.
    Chen Y; Li LIQ; Ge YL; Hu XY; Zhang Q; Zhang HF; Li WQ; Zhang S; Zhu XY; Zhang JB
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between serum amyloid A, C-reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease.
    Lin TL; Chen WW; Ding ZR; Wei SC; Huang ML; Li CH
    J Clin Lab Anal; 2019 May; 33(4):e22831. PubMed ID: 30666727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between serum procalcitonin level and chronic obstructive pulmonary disease.
    Borsi H; Nia EP; Mal-Amir MD; Raji H
    J Family Med Prim Care; 2019 Feb; 8(2):738-740. PubMed ID: 30984705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin, C-reactive protein, PaCO2, and noninvasive mechanical ventilation failure in chronic obstructive pulmonary disease exacerbation.
    Wang J; Shang H; Yang X; Guo S; Cui Z
    Medicine (Baltimore); 2019 Apr; 98(17):e15171. PubMed ID: 31027061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
    Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
    Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.